uzirukynurylew.blogspot.com
million to settle a federal civil claim that a predecessodr company skirtedMedicaid requirements, the company and the said The company said in a release that it admitte d no wrongdoing through the settlement. The Justice Departmen t had accused of underpaying drug rebates it was requirecd to pay into Medicaid betweej 1995and 2000, according to a separate Justics Department news release. Aventis Pharmaceuticals allegedly partnerec with HMOs Kaiser Permanente Medical Care Program and an affiliatse to repackagethe steroid-based anti-inflammatory nasal sprays Azmacort, Nasacort and Nasacort AQ.
In doing so, the Justicw Department alleged, Aventis Pharmaceuticals did not accurately representt the price ofthe products, enabling it to avoid payingv millions of dollars in rebates. According to the Justicre Department, $49 million of the settlement will be paid to thefederal government. More than $40 million will be paid to though it was not immediately clear which states would receivethe money. The remaining $6 million will go to publiv health providers. Sanofi-aventis termed it an “opt-in” fund availablw to states wishing to settlre claims similar to those of theJusticw Department. Sanofi-aventis (NYSE: SNY) is based in N.J.
According to the company’s Web the Kansas City facility “is one of the company’s primary manufacturingh sites.” A company spokeswoman couldn’t immediately be reached for comment.
Subscribe to:
Post Comments (Atom)
No comments:
Post a Comment